There he studies rhetorics of science and medicine and critical/cultural technical communication. Scott has particular interests in the (medico-)science-policy interface, the nature of expertise, and multiple ontologies theory. His research explores communicative conflicts and argumentative practices in the intersections among scientific research and regulatory policy. Currently, he is exploring these issues through inquiry into two different cases: 1) FDA regulation and multidisciplinary pain science and 2) the participation of diverse stakeholders in FDA oncological drugs advisory committee.